Amgen Criticizes Draft Report Before Publication

Amgen is criticizing ICER’s assessments in a recent draft report that hasn’t even been published yet. Find out more here. (Source: Jaimy Lee, MM&M, 4/5/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Real World Data and Evidence: Payer Insights 09/26/2019
CMS Chief Criticizes High Launch Prices 12/02/2019
NPC Disputes ICER Report on Unjustified Price Hikes 10/08/2019
Engaging with ICER: Lessons and insights for pharma 06/12/2020
Scientific Research And Development Services Global Market… 06/19/2020
Evolving Health Economy Puts More Emphasis on Strategy Leaders 11/23/2019